Zettl UK - Search Results

1

Current issues in immunomodulatory treatment of multiple sclerosis--a practical approach.

Stangel M, Gold R, Gass A, Haas J, Jung S, Elias W, Zettl UK. Stangel M, et al. Among authors: zettl uk. J Neurol. 2006 Feb;253 Suppl 1:I32-6. doi: 10.1007/s00415-006-1108-9. J Neurol. 2006. PMID: 16477485 No abstract available.

2

Frequency of current utilisation of complementary and alternative medicine by patients with multiple sclerosis.

Apel A, Greim B, König N, Zettl UK. Apel A, et al. Among authors: zettl uk. J Neurol. 2006 Oct;253(10):1331-6. doi: 10.1007/s00415-006-0217-9. Epub 2006 Jun 19. J Neurol. 2006. PMID: 16786211

3

Intravenous immunoglobulins as therapeutic option in the treatment of multiple sclerosis.

Dudesek A, Zettl UK. Dudesek A, et al. Among authors: zettl uk. J Neurol. 2006 Sep;253 Suppl 5:V50-8. doi: 10.1007/s00415-006-5007-x. J Neurol. 2006. PMID: 16998754 Review.

4

Diagnostics of cognitive dysfunctions in multiple sclerosis.

Engel C, Greim B, Zettl UK. Engel C, et al. Among authors: zettl uk. J Neurol. 2007 May;254 Suppl 2:II30-4. doi: 10.1007/s00415-007-2009-2. J Neurol. 2007. PMID: 17503126 Review.

5

Cognitive impairment in multiple sclerosis.

Winkelmann A, Engel C, Apel A, Zettl UK. Winkelmann A, et al. Among authors: zettl uk. J Neurol. 2007 May;254 Suppl 2:II35-42. doi: 10.1007/s00415-007-2010-9. J Neurol. 2007. PMID: 17503127 Review.

6

Transcranial brain sonography findings related to neuropsychological impairment in multiple sclerosis.

Walter U, Horowski S, Benecke R, Zettl UK. Walter U, et al. Among authors: zettl uk. J Neurol. 2007 May;254 Suppl 2:II49-52. doi: 10.1007/s00415-007-2012-7. J Neurol. 2007. PMID: 17503129 Review.

7

Qualitative and quantitative assessment of fatigue in multiple sclerosis (MS).

Greim B, Benecke R, Zettl UK. Greim B, et al. Among authors: zettl uk. J Neurol. 2007 May;254 Suppl 2:II58-64. doi: 10.1007/s00415-007-2014-5. J Neurol. 2007. PMID: 17503131

8

Animal models of multiple sclerosis for the development and validation of novel therapies - potential and limitations.

Mix E, Meyer-Rienecker H, Zettl UK. Mix E, et al. Among authors: zettl uk. J Neurol. 2008 Dec;255 Suppl 6:7-14. doi: 10.1007/s00415-008-6003-0. J Neurol. 2008. PMID: 19300954 Review.

9

Monitoring of multiple sclerosis immunotherapy: from single candidates to biomarker networks.

Goertsches RH, Hecker M, Zettl UK. Goertsches RH, et al. Among authors: zettl uk. J Neurol. 2008 Dec;255 Suppl 6:48-57. doi: 10.1007/s00415-008-6010-1. J Neurol. 2008. PMID: 19300960 Review.

10

Compliance, adherence, and the treatment of multiple sclerosis.

Klauer T, Zettl UK. Klauer T, et al. Among authors: zettl uk. J Neurol. 2008 Dec;255 Suppl 6:87-92. doi: 10.1007/s00415-008-6016-8. J Neurol. 2008. PMID: 19300966 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

345 results

Search Page

Filters